Skip to main content
All Posts By

admin

P2P logo

Where are the Leading Technology Clusters in Canada and the U.S.: A Webinar Discussion Previewing Issues AURP Will Feature at #AURPIC2022 in Toronto (September 19-22)

By News Archive

P2P logoA state’s competitiveness in the innovation economy stems from the extent of its involvement in the global economy, its capacity for innovation, and its cultivation of a knowledge-based workforce. Massachusetts, California, Ontario, Maryland, and Washington rank highest among North American states in ITIF’s index scoring subnational innovation competitiveness. Canadian provinces overrepresent among North America’s most competitive states in the innovation economy. Ontario ranks third, British Columbia fourth, and Quebec nineth. Mexico’s industrially intensive states are among its most innovative: Nuevo Leon, Baja California, Chihuahua, and Tamaulipas are some of the highest-ranking Mexican states. Cross-border innovation clusters are taking shape in the Pacific Northwest’s life-sciences industry and in the next-generation automobile and semiconductor industries near the U.S.-Mexico border. Canadian, U.S., and Mexican states should leverage each other’s comparative advantages in different phases of innovation in order to build North American global value chains that are cost-competitive with Asia.

Click here to register.

DCM Logo

Service Coordinator

By Uncategorized

DCM Logo

The Service Coordinator is the initial and primary point-of-contact for all DCM BioServices clients. They are responsible for interfacing with our clients and the DCM team to coordinate the delivery and reporting of all repairs and services. They also have a desire to provide the highest levels of client service, be an advocate for DCM BioServices, and be eager to drive growth.

Click here for more information or to apply.

FastForward

Johns Hopkins made an inventor’s guide to help its technologists commercialize. But it can help others, too – Technical.ly

By News Archive

FastForwardWith the support of its homegrown Johns Hopkins Technology Ventures (JHTV), Baltimoreโ€™s oldest private university has helped many of its own students and faculty bring their technological innovations to market โ€” and with wildly successful results. Now, JHTV has a new guide to make the process even easier for those within and beyond its namesake schoolโ€™s community to understand.

Image: ย Inside a Johns Hopkins Technology Ventures FastForward innovation hub.ย (Courtesy photo)

Read More
MII Team Photo

TEDCOโ€™s Maryland Innovation Initiative helps propel ideas from the lab to the marketplace – Technical.ly

By News Archive

MII Team PhotoKubanda Cryotherapy cofounder Bailey Surtees was building the foundation for her company as an undergraduate at Johns Hopkins University (JHU) before she knew it. In 2016, she was researching how to make breast cancer treatment more affordable and accessible for low- and middle-income countries. Surtees surmised that cryotherapy was the ideal solution because it doesnโ€™t require a sterile operating room or anesthesia. Thus, she began developing a probe that could be used for this treatment.

Image: ย The team behind TEDCO’s Maryland Innovation Initiative.ย (Courtesy photo)

Read More
EDA awards 1 6M to Maryland for small businesses Maryland Business News

EDA awards $1.6M to Maryland for small businesses | Maryland Business News

By News Archive

EDA awards 1 6M to Maryland for small businesses Maryland Business NewsA $1.6 million grant has been awarded to the state of Maryland from the Economic Development Administration’s American Rescue Plan.

The federal funding will go towards the Maryland Economic Adjustment Fund (MEAF), administered by the Maryland Department of Commerce, and will be used to assist underserved small businesses across the state.

The MEAF revolving loan fund will serve businesses that do not qualify for traditional financing or lending sources. According to the EDA, this investment could help create 250 new jobs and generate a private investment of $210,000 in Maryland.

ย 

Read More
emergent logo

Emergent BioSolutions and Ridgeback Biotherapeutics Enter Into Agreement for Ebangaโ„ข Treatment for Ebola

By News Archive

emergent logoGAITHERSBURG, Md. and MIAMI, July 07, 2022 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has entered into an agreement with Ridgeback Biotherapeutics (โ€œRidgeback Bioโ€), a biotechnology company focused on emerging infectious diseases, intended to create a collaboration to expand the availability of Ebangaโ„ข (Ansuvimab-zykl). Under the terms of the contemplated collaboration, Emergent will be responsible for the manufacturing, sale, and distribution of Ebangaโ„ข in the United States and Canada, and Ridgeback Bio will serve as the global access partner for Ebangaโ„ข, ensuring it remains available to patients in endemic countries free of charge through Ridgeback Bioโ€™s compassionate use program. Ebangaโ„ข was approved by the U.S. Food and Drug Administration (FDA) in December 2020 for the treatment of Ebola.

Read More
Nobile Life Sciences Logo

Study Director

By Uncategorized

Nobile Life Sciences LogoIn this role you will: 

  1. Overall responsibility for the conduct of the assigned study as well as the interpretation, analysis, documentation, and reporting of results.
  2. Conducting the study in accordance with GLP regulations, the protocol, and Noble Life Sciences (NLS) SOPs.
  3. Defining: staffing, supplies, equipment, and space requirements for the study and assuring those test systems are as specified in the protocol.
  4. Notifying testing facility management which animal rooms and personnel will be required for the study.
  5. Preparing the study protocol and getting signed approval from the sponsor, testing facility manager, and pertinent subcontractors.
  6. Defining and coordinating subcontractor support requirements.
  7. Preparing IACUC documentation and submitting it to the IACUC committee for approval.

And Much More…. 

Read More
Nobile Life Sciences Logo

Study Director (PharmTox)

By Uncategorized

Nobile Life Sciences LogoIn this role you will: 

  • Serve as a Study Director for non-GLP and GLP-compliant non-clinical toxicology studies.
  • Be responsible for study design and execution.
  • Supervise of technical staff.
  • Conduct data analysis and interpretation
  • Prepare study reports in compliance with regulatory requirements.
  • Study design, proposal preparation, and extensive interactions with sponsor representatives are essential functions.
  • Other related duties as assigned.
Read More
Nobile Life Sciences Logo

Study Director (Medical Device)

By Uncategorized

Nobile Life Sciences LogoIn this role you will: 

  • Serve as a Study Director for non-GLP and GLP-compliant Medical Device efficacy and toxicology studies.
  • Be responsible for study design and execution.
  • Supervise of technical staff.
  • Conduct data analysis and interpretation
  • Prepare study reports in compliance with regulatory requirements.
  • Study design, proposal preparation, and extensive interactions with sponsor representatives are essential functions.
  • Other related duties as assigned.
Read More

515th Edition, July 6, 2022

By BHI Weekly Newsletter Archives





Trouble Viewing This Email: Click Here
 

July 6, 2022

FOUNDING MEMBER OF

5th Annual BioHealth Capital Region - Investment Conference

 

2022 Crab Trap Application

Crab Trap 2022 applications are being accepted through August 31st! Entrepreneurs with innovative diagnostics, medical devices, therapeutics, or other transformative health solutions are invited to apply to the 7th annual BioHealth Capital Region Crab Trap pitch competition. Finalists for the 2022 Crab Trap competition will pitch IN PERSON on September 21st as part of the BioHealth Capital Region Investor Conference. The winning teams will receive cash prizes from our sponsors.

Applications are due by 5pm on Wednesday, August 31st. Crab Trap finalists will be notified the week of 9/5/22. Mandatory virtual pitch coaching for all finalists will take place the week of 9/12/22.

Read More

 

NIH/BHI Seeks Life Science Business Analyst

BioHealth Innovation, Inc. (BHI), is a Montgomery County innovation intermediary which translates market-relevant research into commercial success by bringing together management, funding, and markets.  BHI is seeking a life science business analyst to support the NIH SEED Office (https://seed.nih.gov/). The analyst will provide business landscape analysis and other project support on product development, corporate strategy, and private investment for NIH-funded companies. This will entail market landscape, technology, and other business intelligence research to support Entrepreneur-in-Residence and other SEED life science commercialization activities.

Click here for more information.

Read More

BioHealth Innovation is seeking a Senior Life Sciences Business Strategist

BioHealth Innovation, Inc., (BHI) is a regional non-profit innovation intermediary, which facilitates the development of growth-stage biohealth companies by connecting commercially relevant research assets to appropriate funding, management and markets.

JOB TITLE – Senior Life Sciences Business Strategist

Reporting to the Vice President of Economic Development, the Senior Life Sciences Business Strategist evaluates the commercial potential of emerging technologies and provides recommendations on go-to- market strategies. This is a customer facing role with a focus on supporting clients in the development of commercial analyses and federal grant proposals.

The Senior Life Sciences Business Strategist also supervises junior Life Sciences Business Strategists and manages consultants and interns, as needed.

Click here to download a PDF with the details.

Read More

How can your BioHealth business benefit from a review by BHI industry experts? Please register for our next Entrepreneur-In-Residence (EIR) day on July 20th and find out. To sign-up for any of the EIR dates in 2022, please follow this link.

These free 1:1 virtual sessions are an opportunity to discuss your company with experts in diagnostics, therapeutics, digital health and medical devices. If you’re a growth-stage biohealth company looking for unbiased advice on your pitch deck, commercialization strategy, evidence development or entrepreneurial challenges, our EIRs can help.

To sign-up for any of the EIR dates in 2022, please follow this link.

Read More

 

Maryland Inno – TEDCO seeks firm to provide recommendations on creating possible $500M fund

The Maryland Technology Development Corp. is searching for a firm to assess Maryland’s current economic development strategy and make recommendations to help shape the creation of a possible $500 million fund.

TEDCO issued a request for proposal (RFP) for firms to conduct the study earlier this week. The research will be used by TEDCO to help create draft legislation for the Maryland Equitech Growth Fund, which has a recommended minimum of $500 million worth of public investment over a 10-year period. The study is being done at the behest of the Maryland legislature, which called on TEDCO to create the report.

Image: TEDCO, led by CEO Troy LeMaile-Stovall, is searching for a firm to assess Maryland's current economic development strategy. TEDCO

Read More

AMPEL BioSolutions' Precision Medicine Breakthrough  Predicts Drug Options with RNA Analytics & Machine Learning

AMPEL BioSolutions' Precision Medicine Breakthrough AMPEL BioSolutions' Precision Medicine Breakthrough Predicts Drug Options with RNA Analytics & Machine Learning CHARLOTTESVILLE, Va., July 6, 2022 — AMPEL BioSolutions today announces a breakthrough in precision and personalized medicine that could modernize the way doctors treat patients across a wide variety of diseases including autoimmunity, infectious disease and cancer.  Revealed at the Precision Medicine World Conference in Silicon Valley California, the first-in-class platform technology utilizes RNA analytics and machine learning to characterize an individual’s gene expression and provide clinical decision support to physicians for treatment options for their patients.  The technology, only a concept for the last few years, is being utilized to launch a portfolio of 10+ clinical tests over the next five years to provide decision support for diseases that affect more than 50 million Americans.

Read More

Home | About BHI | BHI News | Programs | Partners | Contact

Copyright AA(C) BioHealth Innovation 2021
All Rights Reserved.


Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.